ridinilazole and Cross-Infection

ridinilazole has been researched along with Cross-Infection* in 1 studies

Other Studies

1 other study(ies) available for ridinilazole and Cross-Infection

Article	Year
Update on Clostridium difficile from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, April 22-25, 2017. The Journal of hospital infection, 2018, Volume: 98, Issue:1 Topics: Anti-Bacterial Agents; Benzimidazoles; Biological Therapy; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Transmission, Infectious; Epidemiological Monitoring; Europe; Hospital Costs; Humans; Infection Control; Pyridines; Recurrence; Ribotyping; Survival Analysis; Treatment Outcome	2018

Article

Year

Update on Clostridium difficile from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, April 22-25, 2017.

The Journal of hospital infection, 2018, Volume: 98, Issue:1

Topics: Anti-Bacterial Agents; Benzimidazoles; Biological Therapy; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Transmission, Infectious; Epidemiological Monitoring; Europe; Hospital Costs; Humans; Infection Control; Pyridines; Recurrence; Ribotyping; Survival Analysis; Treatment Outcome

2018